Voltammetric determination of fenbendazole in veterinarian formulations

dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorde Oliveira, M. F.
dc.creatorStradiotto, Nelson Ramos
dc.date2014-05-20T15:22:39Z
dc.date2016-10-25T17:56:23Z
dc.date2014-05-20T15:22:39Z
dc.date2016-10-25T17:56:23Z
dc.date2002-09-05
dc.date.accessioned2017-04-05T23:37:52Z
dc.date.available2017-04-05T23:37:52Z
dc.identifierJournal of Pharmaceutical and Biomedical Analysis. Oxford: Pergamon-Elsevier B.V., v. 30, n. 2, p. 279-284, 2002.
dc.identifier0731-7085
dc.identifierhttp://hdl.handle.net/11449/33596
dc.identifierhttp://acervodigital.unesp.br/handle/11449/33596
dc.identifier10.1016/S0731-7085(02)00339-4
dc.identifierWOS:000178465900013
dc.identifierhttp://dx.doi.org/10.1016/S0731-7085(02)00339-4
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/877683
dc.descriptionA versatile voltammetric method for quantitative determination of fenbendazole (FBZ) in commercial tablets has been proposed, where direct dissolution of tablets is carried out in 0.1 mol l(-1) tetrabutylamoniun tetrafluorborate containing dimethylformamide solutions. Linear sweep (LSV), square wave (SWV) and differential pulse (DPV) voltammetry techniques were applied to study FBZ at a glassy carbon electrode, exhibiting a well defined irreversible oxidation peak at 1.15 V vs. SCE. This methodology allows a precise quantitative determination of FBZ presenting detection limits of 5.2 x 10(-5) (LSV), 5.0 x 10(-6) (DPV) and 5.0 x 10(-5) mol l(-1) (SWV). (C) 2002 Elsevier B.V. B.V. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationJournal of Pharmaceutical and Biomedical Analysis
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectfenbendazole
dc.subjectanthelmintic
dc.subjectvoltammetric determination
dc.titleVoltammetric determination of fenbendazole in veterinarian formulations
dc.typeOtro


Este ítem pertenece a la siguiente institución